Sponsor
Morgan Luttrell
Representative · R-TX
Representative · R-TX
The bill increases U.S. leverage and prevents potential military diversion of U.S.-origin medical goods to pressure Russia, but does so at the risk of cutting off medical access for civilians, hurting U.S. exporters, and complicating humanitarian relief and compliance.
U.S. national security and policymakers gain leverage by blocking exports of U.S.-made drugs, medical devices, and prosthetics to Russia until it withdraws from Ukraine, and this reduces the risk that U.S.-origin medical products will be diverted to support Russian military operations.
Exporters, regulators, and enforcement agencies get a predictable, time-limited legal framework (certification-triggered sanction) that clarifies when the export block applies and how compliance will be enforced.
Patients in Russia who depend on U.S.-approved medicines, prosthetics, or related medical supplies may lose access to essential treatments and devices.
U.S. manufacturers and exporters of drugs, prosthetics, and related medical goods could lose export revenue, face supply-chain disruptions, and suffer harm to business relationships.
Humanitarian organizations, hospitals, and state or local governments involved in overseas medical assistance may face program interruptions, increased compliance burdens, and diplomatic criticism because the bill does not clearly specify humanitarian exceptions.
Based on analysis of 2 sections of legislative text.
Requires the President to bar exports of FDA-approved drugs and FDA-authorized prosthetics to Russia until the Secretary of State certifies Russian withdrawal from Ukraine.
Official title: To prohibit the export of drugs and prosthetics to the Russian Federation.
Introduced July 25, 2025 by Morgan Luttrell · Last progress July 25, 2025
Prohibits the export of any FDA-approved drug or FDA-authorized prosthetic to the Russian Federation until the Secretary of State certifies that Russian forces have stopped military operations in and withdrawn from Ukraine. The ban covers finished products and components, and it stays in place until the specified certification is transmitted to Congress.